Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae

International Journal of Antimicrobial Agents

Volumn 17, Issue 6, 2001, Pages 451-455

  Rospide, Maria Fernanda ^a   Biedenbach, Douglas J ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

ABT 773; Gram positive; Ketolides

Indexed keywords

CETHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; HMR 3004; KETOLIDE; MACROLIDE; OXACILLIN; TELITHROMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GRAM POSITIVE COCCI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; ERYTHROMYCIN; GRAM-POSITIVE COCCI; HAEMOPHILUS INFLUENZAE; HUMANS; KETOLIDES; MACROLIDES; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035018240     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00332-6     Document Type: Article

References (18)

1. Bacterial resistance: a worldwide problem
2. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group
3. Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY antimicrobial surveillance program (North America, 1997-1999)
4. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group
5. Ketolides and other derivatives
6. Ketolides lack inducibility properties of MLS(B) resistance phenotype
7. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides
8. Studies of the novel ketolide ABT-773: transport, binding to ribosomes and inhibition of protein synthesis in Streptococcus pneumoniae
9. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
10. Antipneumococcal activity of ABT-773 compared to those of 10 other agents
11. In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae
12. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections
13. Invitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori
14. Determination of MIC quality control ranges for ABT-773, a novel ketolide antimicrobial agent
15. Antimicrobial activity of RU-66647, a new ketolide
16. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
17. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents